Literature DB >> 19433338

Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.

Ligang Xing1, Xiaorong Sun, Xuelong Deng, Khushali Kotedia, Muneyasu Urano, Jason A Koutcher, C Clifton Ling, Gloria C Li.   

Abstract

PURPOSE: To test the hypothesis that, with 5-fluorocytosine (5-FC) treatment, the co-expression of cytosine deaminase (CD) and uracil phosphoribosyltransferase (UPRT) can lead to greater radiosensitization and bystander effect than CD-expression alone. METHODS AND MATERIALS: R3327-AT cell lines stably expressing CD or CDUPRT were generated. The 5-FC and 5-FU cytotoxicity, and the radiosensitivity with/without 5-FC treatment, of these cells were evaluated under both aerobic and hypoxic conditions. The bystander effect was assessed by apoptosis staining and clonogenic survival. The pharmacokinetics of 5-FU and 5-FC metabolism was monitored in mice bearing CD- or CDUPRT-expressing tumors using 19F MR spectroscopy (MRS).
RESULTS: CDUPRT-expressing cells were more sensitive to 5-FC and 5-FU than CD-expressing cells. CDUPRT-expression further enhanced the radiosensitizing effect of 5-FC, relative to that achieved by CD-expression alone. A 25-fold lower dose of 5-FC resulted in the same magnitude of radiosensitization in CDUPRT-expressing cells, relative to that in CD-expressing cells. The 5-FC cytotoxicity in co-cultures of parental cells mixed with 10-20% CDUPRT cells was similar to that in 100% CDUPRT cells. 19F MRS measurements showed that expression of CDUPRT leads to enhanced accumulation of fluorine nucleotide (FNuc), relative to that associated with CD-expression alone.
CONCLUSION: Our study suggests that CDUPRT/5-FC strategy may be more effective than CD/5-FC, especially when used in combination with radiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433338      PMCID: PMC2830274          DOI: 10.1016/j.radonc.2009.04.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  23 in total

1.  Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy.

Authors:  Heike Corban-Wilhelm; Volker Ehemann; Gabriele Becker; Ditmar Greulich; Klaus Braun; Jürgen Debus
Journal:  Cancer Gene Ther       Date:  2004-03       Impact factor: 5.987

2.  Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization.

Authors:  H S Hwang; T W Davis; J A Houghton; T J Kinsella
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.

Authors:  H Corban-Wilhelm; W E Hull; G Becker; U Bauder-Wüst; D Greulich; J Debus
Journal:  Gene Ther       Date:  2002-12       Impact factor: 5.250

4.  The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

Authors:  Daniel A Hamstra; Kuei C Lee; Joseph M Tychewicz; Victor D Schepkin; Bradford A Moffat; Mark Chen; Kenneth J Dornfeld; Theodore S Lawrence; Thomas L Chenevert; Brian D Ross; Juri T Gelovani; Alnawaz Rehemtulla
Journal:  Mol Ther       Date:  2004-11       Impact factor: 11.454

5.  Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.

Authors:  E Kievit; M K Nyati; E Ng; L D Stegman; J Parsels; B D Ross; A Rehemtulla; T S Lawrence
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

6.  Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein.

Authors:  Ligang Xing; Xuelong Deng; Khushali Kotedia; Ellen Ackerstaff; Vladimir Ponomarev; C Clifton Ling; Jason A Koutcher; Gloria C Li
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

7.  Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes.

Authors:  Hirokazu Kambara; Takashi Tamiya; Yasuhiro Ono; Shinji Ohtsuka; Kinya Terada; Yoshiaki Adachi; Tomotsugu Ichikawa; Hirofumi Hamada; Takashi Ohmoto
Journal:  Cancer Gene Ther       Date:  2002-10       Impact factor: 5.987

8.  Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

Authors:  B A Teicher; J S Lazo; A C Sartorelli
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

Review 9.  Metabolism of pyrimidine analogues and their nucleosides.

Authors:  G C Daher; B E Harris; R B Diasio
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

10.  Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

Authors:  B E Huber; E A Austin; C A Richards; S T Davis; S S Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

View more
  7 in total

1.  Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.

Authors:  Long-Ying Deng; Jian-Ping Wang; Zhi-Fu Gui; Li-Zong Shen
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo.

Authors:  Xiaorong Sun; Ligang Xing; Xuelong Deng; Hung Tsung Hsiao; Akiko Manami; Jason A Koutcher; C Clifton Ling; Gloria C Li
Journal:  Radiother Oncol       Date:  2012-08-29       Impact factor: 6.280

3.  Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth.

Authors:  Ilaria T Cavarretta; Veronika Altanerova; Miroslava Matuskova; Lucia Kucerova; Zoran Culig; Cestmir Altaner
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

4.  Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.

Authors:  A J Johnson; A Ardiani; M Sanchez-Bonilla; M E Black
Journal:  Cancer Gene Ther       Date:  2011-03-11       Impact factor: 5.987

5.  A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions.

Authors:  L Xing; X Sun; X Deng; K Kotedia; P B Zanzonico; E Ackerstaff; J A Koutcher; C C Ling; G C Li
Journal:  Cancer Gene Ther       Date:  2013-05-31       Impact factor: 5.987

6.  Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cells.

Authors:  Hung Tsung Hsiao; Ligang Xing; Xuelong Deng; Xiaorong Sun; C Clifton Ling; Gloria C Li
Journal:  Oncol Rep       Date:  2014-06-06       Impact factor: 3.906

7.  A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy.

Authors:  Yoon Khei Ho; Jun Yung Woo; Geraldine Xue En Tu; Lih-Wen Deng; Heng-Phon Too
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.